NASDAQ · Drug Manufacturers - Specialty & Generic

CPIX (CPIX) Stock

$6.87 -2.28% NASDAQ: CPIX Healthcare

Valuation

MetricValue
Price$6.87
Market Cap$102.93M
P/E Ratio-28.95
P/B Ratio3.30
P/S Ratio1.97
EPS (TTM)$0.00
52-Week High$7.85
52-Week Low$1.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-12.00%
ROA-3.90%
ROCE-12.00%
Gross Margin-4.44%
Operating Margin-6.67%
Net Margin-17.24%
Debt/Equity0.47
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$36.0M$42.0M$40.0M$38.0M$45.0M
Operating Profit$-8.0M$-6.0M$-10.0M$-6.0M$-3.0M
Net Profit$-4.0M$-6.0M$-6.0M$-6.0M$-3.0M
EPS$-0.24$-0.38$-0.44$-0.46$-0.19
Op Margin-21.3%-13.6%-24.2%-17.0%-6.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$84.0M$93.0M$82.0M$76.0M$77.0M
Total Liabilities$42.0M$57.0M$53.0M$53.0M$52.0M
Cash$27.0M$20.0M$18.0M$18.0M$11.0M
Borrowings$16.0M$21.0M$18.0M$21.0M$10.0M

Latest News

ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? Zacks · Jul 15, 2026 Cumberland Declares Special Dividend, Approves $5 Million Share Buyback MT Newswires · Jul 13, 2026 /C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./ PR Newswire · Jul 13, 2026 Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals CNW Group · Jul 1, 2026 Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex PR Newswire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.0M$8.0M$6.0M$-1.0M$5.0M
Investing Cash Flow$-1.0M$-16.0M$-1.0M$0$-5.0M
Financing Cash Flow$-4.0M$-3.0M$-4.0M$-2.0M$3.0M
Net Cash Flow$2.0M$-7.0M$-1.0M$0$-7.0M
Free Cash Flow$6.0M$6.0M$6.0M$-1.0M$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA40.70
FCF Yield1.61%
Quick Ratio0.79
Interest Coverage—
Return 1Y110.86%
Return 3Y392.00%
Return 5Y133.54%

Ownership

Insiders Held41.60%
Institutions Held18.65%
Institutions Float Held31.93%
Institutional HolderSharesReport Date
Ikarian Capital, LLC553,1532026-03-31
Renaissance Technologies, LLC470,6962026-03-31
Vanguard Capital Management LLC361,7592026-03-31
Dimensional Fund Advisors LP276,3592026-03-31
Perceptive Advisors Llc196,9782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABVC $1.04 -3.70% -2.82 $15.07M 0.00%
CALCCalciMedica, Inc. $0.73 -3.82% -0.57 $11.55M 0.00%
CELUCelularity Inc. $0.75 +0.13% -0.20 $21.74M 0.00%
DYAIDyadic International, Inc. $1.17 -1.68% -5.59 $42.63M 0.00%
LTRN $2.63 -0.75% -2.02 $33.56M 0.00%

About CPIX

CPIX is led by CEO A. J. Kazimi, employs 91 people, headquartered in US, publicly traded since 2009.

CPIX stock trades at $6.87 with a market capitalization of $102.93M. The stock is valued at a price-to-earnings (P/E) ratio of -28.95, price-to-book of 3.30, price-to-sales of 1.97. Over the past 52 weeks the stock has ranged between $1.85 and $7.85, and currently trades 12.5% below its 52-week high.

On profitability, CPIX generates a return on equity (ROE) of -12.00%, return on capital employed of -12.00%, an operating margin of -6.67%, a net profit margin of -17.24%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides